EEOC May End DecadesOld Demographic Data Collection Requirement Reshaping Workplace Discrimination Enforcement 30 Nifty Stocks Wipe Out Rs 2264 Lakh Crore in Investor Wealth This Year HDFC Bank and TCS Lead Decline Artificial Intelligence Reshapes Investment Management Deloitte Highlights Transformative Potential SpaceX OpenAI and Anthropic IPOs Could Test the Limits of the AI Boom Ebola Risk Elevated to Very High in DR Congo Potential Implications for Regional Economies and Investors Bessent Forecasts Substantial Disinflation as Warsh Prepares to Lead Federal Reserve Protara Therapeutics TARA Q1 2026 Earnings Narrowerthanexpected loss as cash management supports bottom line BWXT Q1 2026 Earnings Strong EPS Beat Driven by Nuclear Operations Landstar System Inc LSTR Q1 2026 Earnings Modest EPS Beat Amidst Revenue Uncertainty NIQ Q1 2026 Earnings Strong EPS Beat of 476 Surprise Driving Positive Stock Reaction UFP Technologies Q1 2026 Earnings EPS Misses Estimates Amid Slight Stock Gains Kyndryl Holdings Inc KD Q1 2026 Earnings EPS Misses Estimates by 61 Shares Dip 216 Dominos Pizza DPZ Holds Steady Near Key Support as Market Awaits Catalyst Pimco Municipal Income Fund II PML Holds Steady Amid Interest Rate Uncertainty Medallion Financial Corp MFIN Slips Slightly as Shares Navigate Key NearTerm Range CooperStandard Holdings CPS Surges Over 5 on High Volume Technicals Point to Further Upside Potential Stitch Fix SFIX Bounces Analyzing the 345 Uptick and Key Levels Consumers Powering Through Resilience in Spending Amidst Economic Headwinds Potential Impact of Ebola Outbreak on Healthcare and Biotech Investments Federal Reserves Rate Cut Prospects Dim as April Jobs Data Points to Stable Labor Market Broadcom Meta Lead 125 Million Semiconductor Research Hub at UCLA Pershing Square IPO Bill Ackmans Hedge Fund Plans Dual Stock Listing on NYSE Oura Health Tech Files Confidentially for IPO Plans Public Debut Futu Reports 25 Revenue Surge in Q1 2026 Driven by Strong Trading Activity CURR Q3 2025 Earnings Strong EPS Surprise as Profitability Emerges Revenue Details Not Disclosed BioLineRx BLRX Rallies 65 as Shares Test Key Resistance Levels